Instalab

Testosterone Panel

See whether your body is actually using the testosterone it makes, not just how much is floating around.

Should you take a Testosterone Panel test?

This test is most useful if any of these apply to you.

Feeling Fatigued or Low Energy
This panel shows whether low or unavailable testosterone is behind your fatigue, not just whether your levels look normal on paper.
Gaining Weight Despite Trying
Excess weight and insulin resistance suppress the binding proteins that control testosterone. This panel reveals that connection.
Struggling to Build or Keep Muscle
Free testosterone drives muscle building. This panel shows whether enough active hormone is reaching your tissues.
Already Managing a Thyroid Condition
Thyroid problems change how tightly your blood holds onto testosterone. This panel catches hormonal ripple effects thyroid tests miss.

About Testosterone Panel

Total testosterone is the number most doctors check, and most doctors stop there. But that single number can be deeply misleading. About 98% of testosterone in your blood is bound to proteins, mostly to a carrier called sex hormone binding globulin (SHBG) and a smaller portion to albumin. Only the tiny unbound fraction, called free testosterone, can enter cells and do its job. Two people with identical total testosterone levels can feel completely different if one has high SHBG locking most of it away.

This panel measures all four pieces of the puzzle: how much testosterone you produce, how much is actually available to your tissues, how tightly your binding proteins are holding on, and the albumin level that rounds out the calculation. Together, these tests reveal your true hormonal status in a way no single test can.

What This Panel Reveals

The panel answers three connected questions. First, is your body producing enough testosterone? Total testosterone provides that answer. The Endocrine Society defines male hypogonadism (clinically low testosterone) as a total testosterone below 300 ng/dL on at least two morning measurements. But production is only the beginning of the story.

Second, how much of that testosterone is biologically active? SHBG is a protein made by the liver that binds testosterone tightly, pulling it out of circulation. When SHBG is high, less testosterone reaches your muscles, brain, and bones, even if total testosterone looks normal. When SHBG is low, more testosterone is free and active, even if total testosterone appears modest. Free testosterone, measured directly or calculated from total testosterone, SHBG, and albumin together, answers this question.

Third, is there a metabolic reason your binding proteins are off? SHBG responds to a surprising number of signals. It rises with aging, thyroid hormone excess, liver disease, and estrogen exposure. It drops with obesity, insulin resistance, type 2 diabetes, and androgen use. A study in the Journal of Clinical Endocrinology and Metabolism following over 1,400 men from the European Male Ageing Study found that SHBG levels independently predicted the development of metabolic syndrome over four years, regardless of testosterone levels.

Why the Combination Matters

If you only measure total testosterone, you can get false reassurance or false alarm. A man with total testosterone of 450 ng/dL and an SHBG of 80 nmol/L may have free testosterone well below the reference range and be experiencing fatigue, low libido, and muscle loss. His total testosterone looks fine on paper. A man with total testosterone of 320 ng/dL and an SHBG of 18 nmol/L may have plenty of free testosterone and feel perfectly well. His total testosterone looks borderline low, but his body is using it efficiently.

Albumin matters because about 50% of circulating testosterone is loosely bound to it. Unlike the tight grip of SHBG, albumin releases testosterone easily, making albumin-bound testosterone functionally available to your tissues. When albumin drops (from liver disease, kidney disease, malnutrition, or chronic inflammation), the calculation of bioavailable testosterone, the portion your body can actually use, shifts. Without knowing your albumin, any calculated free testosterone estimate loses accuracy.

How to Read Your Results Together

The patterns below cover the most common combinations you will see. Each tells a different story about what is happening in your body.

PatternWhat It SuggestsLikely Next Step
Low total testosterone, low free testosterone, normal SHBGTrue testosterone deficiency. Your body is not producing enough.Evaluate with luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to determine whether the problem is in the testes or the brain's signaling system.
Normal total testosterone, low free testosterone, high SHBGHidden deficiency. Production is adequate but SHBG is sequestering too much. Common with aging, thyroid overactivity, or liver conditions.Check thyroid function and liver enzymes. Consider whether medications (such as seizure medications or some antidepressants) are raising SHBG.
Low total testosterone, normal or high free testosterone, low SHBGLikely driven by insulin resistance or obesity. SHBG is suppressed, so more testosterone circulates freely despite low production.Evaluate fasting insulin, HbA1c (a three-month average of blood sugar), and metabolic health. Address weight and insulin sensitivity.
Normal total testosterone, normal free testosterone, normal SHBGHormonal balance is intact. This is the reassuring pattern.Recheck annually if you are tracking over time, or sooner if symptoms develop.

When Results Can Be Misleading

Testosterone levels follow a daily rhythm, peaking in the early morning and dropping 20% to 35% by late afternoon. A blood draw at 3 PM may show levels significantly lower than one at 8 AM. The Endocrine Society recommends morning draws (before 10 AM) for this reason. If your result is borderline, the timing of your draw matters.

Acute illness, poor sleep, high stress, and heavy alcohol use can all temporarily suppress testosterone. A single low result during a stressful week does not necessarily mean you have a chronic problem. Confirming with a repeat test under better conditions is standard practice.

SHBG can be artificially elevated by oral estrogen therapy, hyperthyroidism (an overactive thyroid), or certain liver conditions. It can be suppressed by testosterone or similar hormones taken from outside sources (including over-the-counter supplements containing DHEA, a hormone precursor), high-dose steroid medications like prednisone, and nephrotic syndrome (a kidney condition that causes heavy protein loss in urine). If your SHBG looks unexpectedly high or low, consider whether any of these factors are in play before drawing conclusions.

Tracking Over Time

A single snapshot of testosterone tells you where you are today. Serial testing tells you the direction you are heading. In men, total testosterone declines by roughly 1% to 2% per year after age 30, according to data from the Massachusetts Male Aging Study following over 1,600 men. But this average conceals wide individual variation. Some men maintain stable levels into their 60s while others decline steeply in their 40s.

Tracking your panel over time lets you spot a trend before it becomes a problem. If total testosterone is dropping but SHBG is rising, you know the effective decline in usable testosterone is steeper than total testosterone alone would suggest. If you start an intervention like weight loss or sleep improvement, repeated testing shows whether it is working and whether your binding proteins are responding as expected.

Frequently Asked Questions

References

7 studies
  1. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MAJournal of Clinical Endocrinology and Metabolism2018
  2. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, Mckinlay JBJournal of Clinical Endocrinology and Metabolism2002
  3. Brand JS, Van Der Tweel I, Grobbee DE, Emmelot-vonk MH, Van Der Schouw YTJournal of Clinical Endocrinology and Metabolism2011
  4. Laughlin GA, Barrett-connor E, Bergstrom JJournal of Clinical Endocrinology and Metabolism2008
  5. Wu FC, Tajar a, Beynon JM, Pye SR, Silman AJ, Finn JD, O'neill TW, Bartfai G, Casanueva FF, Forti G, Giwercman a, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Boonen S, Vanderschueren D, Labrie F, Huhtaniemi ITNew England Journal of Medicine2010